After a diagnosis of cancer is made, anatomic staging is performed to describe the rate of growth and the extent of the disease. The practice of dividing cancer cases into groups according to stages arose from the fact that survival rates were higher for cases where the disease was localized than when the disease had spread beyond the organ or site of origin. Staging helps to establish treatment options, predict life expectancy, and determine the prognosis for a complete recovery. Factors noted in staging include:
- Location and size of the primary site of the tumor
- Extent of lymph node involvement
- Presence or absence of metastasis
- Type of tumor and the tumor-host relationship
Tumor (T) codes:
- TX: Cannot be assessed
- T0: No evidence of a primary tumor
- Tis: Carcinoma in situ
- T1, T2, T3, and T4: Increasing size, local extent, or both, of primary tumor
Regional lymph node (N) codes:
- NX: Cannot be assessed
- N0: No metastasis
- N1, N2, and N3: Increasing involvement of regional lymph nodes
The spread of cancer cells from the primary site, or site of origin, is called metastasis. Cancer cells can spread throughout the body through the bloodstream, the lymphatic system, or through local invasion and infiltration into surrounding tissues.
Metastasis (M) codes:
- MX: Cannot be assessed
- M0: No distant metastasis
- M1: Distant metastasis
Combining the TNM Clinical Classification codes leads to the actual tissue staging. The following are the stages of cancer:
Stage | Code | Description |
Stage 0 | Tis | Cancer in situ (encapsulated) |
Stage I | T2, N0, M0 | Cancer is limited to original site or organ |
Stage II | T2, N1, M0 | Cancer has spread to surrounding tissue in same anatomic region |
Stage III | T3, N2, M0 | High probability of metastatic disease |
Stage IV | T4, N3, M1 | Metastatic spread to other anatomic regions |